Onkure Therapeutics, Inc.
Ticker: OKUR
| Insider | Title |
|---|---|
| Alejandro Dorenbaum | Chief Medical Officer |
| Anders D Hove | 10% or greater ownership |
| Andrew John Phillips | Director |
| Ashley Hall | Chief Development Officer |
| Asset Management, Lp Cormorant | 10% or greater ownership |
| Bali Muralidhar | Director |
| Bihua Chen | 10% or greater ownership |
| Bioventures, L.p. Acorn | 10% or greater ownership |
| Braden Michael Leonard | Former 10% owner of RPHM |
| Capital Advisors Gp, Llc Acorn | 10% or greater ownership |
| Dylan Hartley | Chief Scientific Officer |
| Edward T Mathers | Director |
| Eric M Dube | Director |
| Global Healthcare Master Fund, Lp Cormorant | 10% or greater ownership |
| Gregory J. Flesher | President and CEO, Director |
| Isaac Manke | Director |
| Jason A. Leverone | Chief Financial Officer |
| Jennifer Lam | VP of Finance Administration |
| Michael Cruse | Chief Operating Officer |
| Michael G Grey | Director |
| Niall O'donnell | Director |
| Nicholas A Saccomano | President and CEO, Director |
| Paul W. Hoelscher | Director |
| Private Healthcare Fund Iii Lp Cormorant | 10% or greater ownership |
| Private Healthcare Fund Iv Lp Cormorant | 10% or greater ownership |
| Private Healthcare Fund V Lp Cormorant | 10% or greater ownership |
| R Michael Carruthers | Director |
| Samuel Agresta | Chief Medical Officer |
| Stacey Denenberg Seltzer | Director |
| Valerie Malyvanh Jansen | Director |
| Vineet R. Jindal | Chief Financial Officer |
| Wendy S. Johnson | Chief Development Officer |